E-LIB Suche - Ergebnisse für: Hu, Xing-Sheng

1

Recent advances in tunable metal–support interactions for e..:

Wang, Bing-Hao ; Chen, Guang-Hui ; Hu, Biao...
EES Catalysis. 2 (2024) 1 - p. 180-201 , 2024

Link: https://doi.org/10.1039/..

2

Afatinib and Dacomitinib Efficacy, Safety, Progression Patt..:

Li, Hong-Shuai ; Wang, Shou-Zheng ; Xu, Hai-Yan...
Cancers. 14 (2022) 21 - p. 5307 , 2022

Link: https://doi.org/10.3390/..

3

Dacomitinib for Advanced Non-small Cell Lung Cancer Patient..:

Li, Hong-Shuai ; Yang, Guang-Jian ; Cai, Yi...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

4

Rechallenge pemetrexed-based chemotherapy provides an optio..:

Wang, Jia-Ni ; Qiao, Quan-Hui ; Hu, Xing-Sheng...
Chinese Medical Journal. 134 (2021) 17 - p. 2119-2121 , 2021

Link: https://doi.org/10.1097/..

5

Emerging immunotherapy targets in lung cancer:

Zhu, Hao-Hua ; Feng, Yu ; Hu, Xing-Sheng
Chinese Medical Journal. 133 (2020) 20 - p. 2456-2465 , 2020

Link: https://doi.org/10.1097/..

6

Safety, tolerability, and pharmacokinetics of simotinib, a ..:

Hu, Xing-sheng ; Han, Xiao-hong ; Yang, Sheng...
Cancer Management and Research. 11 (2019) - p. 4449-4459 , 2019

Link: https://doi.org/10.2147/..

7

Depth of Response was Associated with Progression-Free Surv..:

Liu, Yu-Tao ; Zhang, Kai ; Li, Cheng-Cheng...
Journal of Cancer. 10 (2019) 21 - p. 5108-5113 , 2019

Link: https://doi.org/10.7150/..

8

Apatinib, a novel VEGFR inhibitor plus docetaxel in advance..:

Duan, Jian-Chun ; Wang, Zhi-Jie ; Lin, Lin...
Investigational New Drugs. 37 (2019) 4 - p. 731-737 , 2019

Link: https://doi.org/10.1007/..

9

Experimental study on the seismic performance of concrete s..:

Yang, Jian ; Li, Ling-Zhi ; Wang, Xin.
Case Studies in Construction Materials. 20 (2024) - p. e02695 , 2024

Link: https://doi.org/10.1016/..

10

Afatinib and Dacomitinib Efficacy, Safety, Progression Patt..:

Li, Hong-Shuai ; Wang, Shou-Zheng ; Xu, Hai-Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656097/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Dacomitinib for Advanced Non-small Cell Lung Cancer Patient..:

Li, Hong-Shuai ; Yang, Guang-Jian ; Cai, Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234690/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Rechallenge pemetrexed-based chemotherapy provides an optio..:

Wang, Jia-Ni ; Qiao, Quan-Hui ; Hu, Xing-Sheng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440023/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Emerging immunotherapy targets in lung cancer:

Zhu, Hao-Hua ; Feng, Yu ; Hu, Xing-Sheng
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575190/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Safety, tolerability, and pharmacokinetics of simotinib, a ..:

Hu, Xing-sheng ; Han, Xiao-hong ; Yang, Sheng...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CMAR.S189626. , 2019

Link: https://www.dovepress.co..

15

Depth of Response was Associated with Progression-Free Surv..:

Liu, Yu-Tao ; Zhang, Kai ; Li, Cheng-Cheng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775600/. , 2019

Link: http://www.ncbi.nlm.nih...